Evangelos Drosos

Mr. Evangelos Drosos


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Surgical Neurology International
Verified
Journal Article
Open access
BABlionas Alexandros
Blionas Alexandros
DGDimitrios Giakoumettis
Dimitrios Giakoumettis
EAElias Antoniades
Elias Antoniades
EDEvangelos Drosos
Evangelos Drosos
MAMitsios Andreas
Mitsios Andreas
TMThemistocleousS Marios
ThemistocleousS Marios
Aplasia cutis congenita (ACC) is a part of a heterogeneous group of conditions characterized by the congenital absence of epidermis, dermis, and in some cases, subcutaneous tissues or bone usually involving the scalp vertex. There is an estimated incidence of 3 in 10,000 births resulting in a total number of 500 reported cases to date. The lesions may occur on every body surface although localized scalp lesions form the most frequent pattern (70%). Complete aplasia involving bone defects occurs in approximately 20% of cases. ACC can occur as an isolated defect or can be associated with a number of other congenital anomalies such as limb anomalies or embryologic malformations. In patients with large scalp and skull defects, there is increased risk of infection and bleeding along with increased mortality and therefore prompt and effective management is advised. We describe two cases of ACC, involving a 4 × 3 cm defect managed conservatively and a larger 10 × 5 cm defect managed surgically with the use of a temporo-occipital scalp flap. Both cases had an excellent outcome. Multiple treatment regimens exist for ACC, but there is no consensus on treatment strategies. Conservative treatment has been described and advocated, but many authors have emphasized the disadvantages of this treatment modality. Decision between conservative and surgical management must be individualized according to lesion size and location.

16 April 2024 in Brain and Spine
Verified
Journal Article
Open access
Cesare ZoiaCesare Zoia
Cesare Zoia
Martin N. StienenMartin N. Stienen
Martin N. Stienen
IZIsmail Zaed
Ismail Zaed
GMGrazia Menna
Grazia Menna
CACristina C. Aldea
Cristina C. Aldea
MGMaria L. Gandía-Gonzalez
Maria L. Gandía-Gonzalez
Imposter syndrome (IS), characterized by persistent doubts about one's abilities and fear of exposure as a fraud, is a prevalent psychological condition, particularly impacting physicians. In neurosurgery, known for its competitiveness and demands, the prevalence of IS remains high. Recognizing the limited literature on IS within the neurosurgical community, this European survey aimed to determine its prevalence among young neurosurgeons and identify associated factors. The survey, conducted by the Young Neurosurgeon Committee of the European Association of Neurosurgical Societies, gathered responses from 232 participants. The survey included demographics, the Clance Imposter Phenomenon Survey (CIPS), and an analysis of potential compensatory mechanisms. Nearly 94% of respondents exhibited signs of IS, with the majority experiencing moderate (36.21%) or frequent (40.52%) symptoms. Analyses revealed associations between IS and factors such as level of experience, sex, and board-certification. The findings suggest a significant prevalence of IS among young neurosurgeons, with notable associations with sex and level of experience. Compensatory mechanisms, such as working hours, article reading, and participation in events, did not show significant correlations with IS. Notably, male sex emerged as an independent protective factor against frequent/intense IS, while reading more than five articles per week was identified as a risk factor. The identification of protective and risk factors, particularly the influence of gender and reading habits, contributes valuable insights for developing targeted interventions to mitigate IS and improve the well-being of neurosurgeons.

11 May 2023 in Neuro-Oncology Practice
Verified
Journal Article
Open access
PDF file
ELEvangelia Liouta
Evangelia Liouta
CKChristos Koutsarnakis
Christos Koutsarnakis
Spyridon KomaitisSpyridon Komaitis
Spyridon Komaitis
Aristotelis KalyvasAristotelis Kalyvas
Aristotelis Kalyvas
EDEvangelos Drosos
Evangelos Drosos
GSGeorge Stranjalis
George Stranjalis
Aim of the present study is to investigate whether preoperative neurocognitive status is prognostically associated with overall survival (OS) in newly diagnosed glioblastoma (GBM) patients. Ninety patients with dominant-hemisphere IDH-wild-type GBM were assessed by Mini Mental Status Exam (MMSE), Trail Making Test (TMT) A and B parts, and Control Word Association Test (COWAT) phonemic and semantic subtests. Demographics, Karnofsky Performance Scale, tumor parameters, type of surgery, and adjuvant therapy data were available for patients. According to Cox proportional hazards model the neurocognitive variables of TMT B (P < .01), COWAT semantic subset (P < .05), and the MMSE (P < .01) were found significantly associated with survival prediction. From all other factors, only tumor volume and operation type (debulking vs biopsy) showed a statistical association (P < .05) with survival prediction. Kaplan Meier Long rank test showed statistical significance (P < .01) between unimpaired and impaired groups for TMT B, with median survival for the unimpaired group 26 months and 10 months for the impaired group, for COWAT semantic (P < .01) with median survival 23 months and 12 months, respectively and for MMSE (P < .01) with medial survival 19 and 12 months respectively. Our study demonstrates that neurocognitive status at baseline—prior to treatment—is an independent prognostic factor for OS in wild-type GBM patients, adding another prognostic tool to assist physicians in selecting the best treatment plan.

7 August 2022 in World Neurosurgery
Verified
Journal Article
Closed access
PSPantelis Stavrinou
Pantelis Stavrinou
EDEvangelos Drosos
Evangelos Drosos
SKSpyridon Komaitis
Spyridon Komaitis
GSGeorgios P. Skandalakis
Georgios P. Skandalakis
NMNektarios K. Mazarakis
Nektarios K. Mazarakis
CKChristos Koutsarnakis
Christos Koutsarnakis

30 September 2022 in Neuro-Oncology Practice
Verified
Journal Article
Open access
PDF file
ELEvangelia Liouta
Evangelia Liouta
Aristotelis KalyvasAristotelis Kalyvas
Aristotelis Kalyvas
Spyridon KomaitisSpyridon Komaitis
Spyridon Komaitis
EDEvangelos Drosos
Evangelos Drosos
CKChristos Koutsarnakis
Christos Koutsarnakis
GSGeorge Stranjalis
George Stranjalis
Background: High-grade glioma (HGG) patients present with variable impairment in neurocognitive function (NCF). Based on that, isocitrate dehydrogenase 1 (IDH1) wild-type HGGs are more aggressive than IDH1 mutant-type ones, we hypothesized that patients with IDH1 wild-type HGG would exhibit more severe NCF deficits than their IDH1 mutant counterparts.Methods: NCF was assessed by Mini Mental Status Exam (MMSE), Trail Making Test (TMT), Digit Span (DS), and Controlled Word Association Test (COWAT) tests in 147 HGG patients preoperatively.Results: Analyses between IDH1 groups revealed a significant difference on MMSE concentration component (p ≤ .01), DS (p ≤ .01), TMTB (p ≤ .01), and COWAT (p ≤ .01) scores, with the IDH1 wild group performing worse than the IDH1 mutant one. Age and tumor volume were inversely correlated with MMSE concentration component (r = −4.78, p < .01), and with MMSE concentration (r = −.401, p < .01), TMTB (r = −.328, p < .01), and COWAT phonemic scores (r = −.599, p < .01), respectively, but only for the IDH1 wild-type group. Analyses between age-matched subsamples of IDH1 groups revealed no age effect on NCF. Tumor grade showed nonsignificance on NCF (p > .05) between the 2 IDH1 mutation subgroups of grade IV tumor patients. On the contrary, grade III group showed a significant difference in TMTB (p < .01) and DS backwards (p < .01) between IDH1 subgroups, with the mutant one outperforming the IDH1 wild one.Conclusions: Our findings indicate that IDH1 wild-type HGG patients present greater NCF impairment, in executive functions particularly, compared to IDH1 mutant ones, suggesting that tumor growth kinetics may play a more profound role than other tumor and demographic parameters in clinical NCF of HGG patients.

26 August 2023 in Brain and Spine
Verified
Journal Article
Open access
Giovanni RaffaGiovanni Raffa
Giovanni Raffa
TSToma Spiriev
Toma Spiriev
CZCesare Zoia
Cesare Zoia
CACristina C. Aldea
Cristina C. Aldea
JJJiri Bartek Jr
Jiri Bartek Jr
MGMaria L. Gandía-González
Maria L. Gandía-González
Technological advancements provided several preoperative tools allowing for precise preoperative planning in cranial neurosurgery, aiming to increase the efficacy and safety of surgery. However, little data are available regarding if and how young neurosurgeons are trained in using such technologies, how often they use them in clinical practice, and how valuable they consider these technologies. How frequently these technologies are used during training and clinical practice as well as to how their perceived value can be qualitatively assessed. The Young Neurosurgeons’ Committee (YNC) of the European Association of Neurosurgical Societies (EANS) distributed a 14-items survey among young neurosurgeons between June 1st and August 31st, 2022. A total of 441 responses were collected. Most responders (42.34%) received “formal” training during their residency. Planning techniques were used mainly in neuro-oncology (90.86%), and 3D visualization of patients' DICOM dataset using open-source software was the most frequently used (>20 times/month, 20.34% of responders). Software for 3D visualization of patients’ DICOM dataset was the most valuable technology, especially for planning surgical approach (42.03%). Conversely, simulation based on augmented/mixed/virtual reality was considered the less valuable tool, being rated below sufficiency by 39.7% of responders. Training for using preoperative planning technologies in cranial neurosurgery is provided by neurosurgical residency programs. Software for 3D visualization of DICOM datasets is the most valuable and used tool, especially in neuro-oncology. Interestingly, simulation tools based on augmented/virtual/mixed reality are considered less valuable and, therefore, less used than other technologies.